Conscious Sedation for Cataract Operations Under Topical Anaesthesia

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Conscious Sedation
Interventions
DRUG

Nalbuphine

i.v. nalbuphine bolus of 50 μg/kg.

DRUG

Propofol

A bolus i.v. dose of propofol 0.5 mg/kg followed by an infusion of 0.025 mg/kg/min

DRUG

Dexmedetomidine

i.v. loading dose of dexmedetomidine 1 μg/kg over 10 min followed by a maintenance infusion of 0.5 μg/kg/h.

DRUG

Benoxinate Hydrochloride 0.4% Eye Drops

Benoxinate hydrochloride 0.4% eye drops instilled twice, 5 minutes apart.

Trial Locations (1)

32511

Faculty of Medicine, Cairo

All Listed Sponsors
lead

Menoufia University

OTHER

NCT03933280 - Conscious Sedation for Cataract Operations Under Topical Anaesthesia | Biotech Hunter | Biotech Hunter